Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5

• TSUKAHARA Tomohide

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• KAWAGUCHI Satoshi

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• TORIGOE Toshihiko

  Department of Pathology, Sapporo Medical University School of Medicine

• ASANUMA Hiroko

  Division of Clinical Pathology, Sapporo Medical University Hospital

• NAKAZAWA Emiri

  Cancer Vaccine Laboratory, Innovation Plaza Hokkaido, Japan Science and Technology Agency

• SHIMOZAWA Kumiko

  Cancer Vaccine Laboratory, Innovation Plaza Hokkaido, Japan Science and Technology Agency

• NABETA Yuki

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• KIMURA Shigeharu

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• KAYA Mitsunori

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• NAGOYA Satoshi

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• WADA Takuro

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• YAMASHITA Toshihiko

  Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine

• SATO Noriyuki

  Department of Pathology, Sapporo Medical University School of Medicine

収録刊行物

• Cancer science

  Cancer science 97 (12), 1374-1380, 2006-12-10

詳細情報

• CRID: 1570854175563099904
• NII論文ID: 10020388005
• NII書誌ID: AA11808050
• ISSN: 13479032
• Web Site: https://search.jamas.or.jp/link/ui/2007142832
• 本文言語コード: en
• データソース種別:
  • CiNii Articles